268 related articles for article (PubMed ID: 19930045)
1. Accelerated induction of mycobacterial antigen-specific CD8+ T cells in the Mycobacterium tuberculosis-infected lung by subcutaneous vaccination with Mycobacterium bovis bacille Calmette-Guérin.
Begum D; Umemura M; Yahagi A; Okamoto Y; Hamada S; Oshiro K; Matsuzaki G
Immunology; 2009 Dec; 128(4):556-63. PubMed ID: 19930045
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary immune responses during primary mycobacterium bovis- Calmette-Guerin bacillus infection in C57Bl/6 mice.
Fulton SA; Martin TD; Redline RW; Henry Boom W
Am J Respir Cell Mol Biol; 2000 Mar; 22(3):333-43. PubMed ID: 10696070
[TBL] [Abstract][Full Text] [Related]
3. Dendritic cells induce CD4+ and CD8+ T-cell responses to Mycobacterium bovis and M. avium antigens in Bacille Calmette Guérin vaccinated and nonvaccinated cattle.
Hope JC; Kwong LS; Sopp P; Collins RA; Howard CJ
Scand J Immunol; 2000 Sep; 52(3):285-91. PubMed ID: 10972905
[TBL] [Abstract][Full Text] [Related]
4. Immune response to Mycobacterium bovis bacille Calmette Guérin infection in major histocompatibility complex class I- and II-deficient knock-out mice: contribution of CD4 and CD8 T cells to acquired resistance.
Ladel CH; Daugelat S; Kaufmann SH
Eur J Immunol; 1995 Feb; 25(2):377-84. PubMed ID: 7875199
[TBL] [Abstract][Full Text] [Related]
5. Activation of CD8 T cells by mycobacterial vaccination protects against pulmonary tuberculosis in the absence of CD4 T cells.
Wang J; Santosuosso M; Ngai P; Zganiacz A; Xing Z
J Immunol; 2004 Oct; 173(7):4590-7. PubMed ID: 15383593
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cells infected with Mycobacterium bovis bacillus Calmette Guerin activate CD8(+) T cells with specificity for a novel mycobacterial epitope.
Feng CG; Demangel C; Kamath AT; Macdonald M; Britton WJ
Int Immunol; 2001 Apr; 13(4):451-8. PubMed ID: 11282984
[TBL] [Abstract][Full Text] [Related]
7. Accelerating the secondary immune response by inactivating CD4(+)CD25(+) T regulatory cells prior to BCG vaccination does not enhance protection against tuberculosis.
Quinn KM; Rich FJ; Goldsack LM; de Lisle GW; Buddle BM; Delahunt B; Kirman JR
Eur J Immunol; 2008 Mar; 38(3):695-705. PubMed ID: 18266274
[TBL] [Abstract][Full Text] [Related]
8. Induction of cytotoxic T-cell responses against culture filtrate antigens in Mycobacterium bovis bacillus Calmette-Guérin-infected mice.
Denis O; Lozes E; Huygen K
Infect Immun; 1997 Feb; 65(2):676-84. PubMed ID: 9009330
[TBL] [Abstract][Full Text] [Related]
9. Bacille Calmette-Guérin vaccination enhances human gamma delta T cell responsiveness to mycobacteria suggestive of a memory-like phenotype.
Hoft DF; Brown RM; Roodman ST
J Immunol; 1998 Jul; 161(2):1045-54. PubMed ID: 9670986
[TBL] [Abstract][Full Text] [Related]
10. Protection against aerosol Mycobacterium tuberculosis infection using Mycobacterium bovis Bacillus Calmette Guérin-infected dendritic cells.
Demangel C; Bean AG; Martin E; Feng CG; Kamath AT; Britton WJ
Eur J Immunol; 1999 Jun; 29(6):1972-9. PubMed ID: 10382760
[TBL] [Abstract][Full Text] [Related]
11. Culture filtrate specific H-2(b) restricted CD8+ T cells activated in vivo by Mycobacterium tuberculosis or bovis BCG recognize a restricted number of immunodominant peptides.
Denis O; Stroobant V; Colau D; D'Souza S; Huygen K
Immunol Lett; 2002 Apr; 81(2):115-24. PubMed ID: 11852116
[TBL] [Abstract][Full Text] [Related]
12. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.
Romano M; D'Souza S; Adnet PY; Laali R; Jurion F; Palfliet K; Huygen K
Vaccine; 2006 Apr; 24(16):3353-64. PubMed ID: 16488518
[TBL] [Abstract][Full Text] [Related]
13. Characterization of human Mycobacterium bovis bacille Calmette-Guérin-reactive CD8+ T cells.
Smith SM; Malin AS; Pauline T; Lukey ; Atkinson SE; Content J; Huygen K; Dockrell HM
Infect Immun; 1999 Oct; 67(10):5223-30. PubMed ID: 10496899
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of human peripheral blood mononuclear cells with live Mycobacterium bovis BCG activates cytolytic CD8+ T cells in vitro.
Turner J; Dockrell HM
Immunology; 1996 Mar; 87(3):339-42. PubMed ID: 8778016
[TBL] [Abstract][Full Text] [Related]
15. Lymphatic tracing and T cell responses following oral vaccination with live Mycobacterium bovis (BCG).
Dorer DE; Czepluch W; Lambeth MR; Dunn AC; Reitinger C; Aldwell FE; McLellan AD
Cell Microbiol; 2007 Feb; 9(2):544-53. PubMed ID: 17018037
[TBL] [Abstract][Full Text] [Related]
16. Vaccination with the T cell antigen Mtb 8.4 protects against challenge with Mycobacterium tuberculosis.
Coler RN; Campos-Neto A; Ovendale P; Day FH; Fling SP; Zhu L; Serbina N; Flynn JL; Reed SG; Alderson MR
J Immunol; 2001 May; 166(10):6227-35. PubMed ID: 11342645
[TBL] [Abstract][Full Text] [Related]
17. Single intranasal mucosal Mycobacterium bovis BCG vaccination confers improved protection compared to subcutaneous vaccination against pulmonary tuberculosis.
Chen L; Wang J; Zganiacz A; Xing Z
Infect Immun; 2004 Jan; 72(1):238-46. PubMed ID: 14688101
[TBL] [Abstract][Full Text] [Related]
18. A DNA prime-live vaccine boost strategy in mice can augment IFN-gamma responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis.
Skinner MA; Ramsay AJ; Buchan GS; Keen DL; Ranasinghe C; Slobbe L; Collins DM; de Lisle GW; Buddle BM
Immunology; 2003 Apr; 108(4):548-55. PubMed ID: 12667217
[TBL] [Abstract][Full Text] [Related]
19. MHC-restricted Ag85B-specific CD8
Komine-Aizawa S; Jiang J; Mizuno S; Hayakawa S; Matsuo K; Boyd LF; Margulies DH; Honda M
Eur J Immunol; 2019 Sep; 49(9):1399-1414. PubMed ID: 31135967
[TBL] [Abstract][Full Text] [Related]
20. Vaccine-elicited 10-kilodalton culture filtrate protein-specific CD8+ T cells are sufficient to mediate protection against Mycobacterium tuberculosis infection.
Wu Y; Woodworth JS; Shin DS; Morris S; Behar SM
Infect Immun; 2008 May; 76(5):2249-55. PubMed ID: 18332205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
